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Abstract
Background:  The mitochondrial voltage-dependent anion channel (VDAC) is increasingly
implicated in the control of apoptosis. We have studied the effects the mitochondrial DNA
(mtDNA) tRNAIle mutation on VDAC expression, localization, and apoptosis.
Methods:  Lymphoblastoid cell lines were derived from 3 symptomatic and 1 asymptomatic
members of a family with hypertension associated with the A4263G tRNAIle mutation as well as
from control subjects. Mitochondrial potential (ΔΨm) and apoptosis were measured by flow
cytometry; co-localization of VDAC and Bax was evaluated by confocal microscopy.
Results: Expression of VDAC and Bax in mtDNA cell lines was found to be increased compared
to controls, while expression of the small conductance calcium-dependant potassium channel
(sKCa) was unchanged. Confocal imaging revealed co-localization of VDAC/Bax on the outer
mitochondrial membrane of A4263G cell lines but not from controls. Flow cytometry indicated
that the mitochondrial potential was decreased by 32% in mutated cells versus controls while rates
of apoptosis were increased (P < 0.05). The difference was attenuated by Cyclosporin A (CsA, 2
μM), a blocker of VDAC.
Conclusion: We conclude that increased expression of mitochondrial VDAC and subcellular co-
localization of VDAC/Bax increases mitochondrial permeability and apoptosis in cell lines carrying
the mtDNA tRNAIle A4263G mutation.
Background
Hypertension is an established risk factor for coronary
heart disease, stroke, congestive heart failure and renal
dysfunction, and is the major modifiable risk factor of
poor prognosis in a variety of cardiovascular diseases.
Multiple environmental and genetic factors are known to
predispose to essential hypertension, with genetic predis-
position contributing to 30-60% of the pathoetiology of
the disease [1]. We previously reported on families with
an inherited disposition to essential hypertension; some
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families showed an obvious pattern of maternal inherit-
ance indicative of a mitochondrial disorder [2-5]. In a pre-
vious study on a large Chinese Han family with
maternally-inherited hypertension we uncovered a muta-
tion in the mitochondrial A4263G tRNAIle  gene. The
mutation was found to affect a nucleotide conserved from
bacteria to human. Importantly, the change was inferred
to influence amino acid charging of tRNA [6] and was
therefore likely to lead to translational amino-acid substi-
tutions in some mitochondrial proteins, with major con-
sequences for mitochondrial function.
Recent studies have reported that the outer mitochondrial
membrane voltage-dependent anion channel (VDAC) is
associated with type 2 diabetes mellitus [7-9], an impor-
tant finding in view of the link between diabetes and
mitochondrial function [10,11]. There are 3 kinds of
VDAC 1 to 3, but in human VDAC1 is highly expressed,
which controls the transit of adenine nucleotides, Ca2+,
and other metabolites [12,13] both into and out of the
mitochondrion. The channel is also a constituent of the
mitochondrial permeability transition pore (PTP) [14-16]
and therefore is likely to play a central role in the control
of apoptosis. To study the link between the mitochondrial
tRNAIle  A4263G mutation, high blood pressure, and
apoptosis we established lymphoblastoid cell lines from
individuals carrying the A4263G mutation and from con-
trols. We report that the A4263G mutation is associated
with changes in VDAC expression, localization, and levels
of apoptosis.
Methods
Cell lines and culture conditions
Informed consent, blood samples were obtained from all
of the participating family members, under protocols
approved by the ethics committee of Chinese PLA General
Hospital and the Cincinnati Children's Hospital Medical
Center Institute Review Board. Lymphoblastoid cell lines
were immortalized by transformation with Epstein-Barr
virus as described elsewhere [17]. Cell lines derived from
4 members of the Chinese family with a maternally-inher-
ited predisposition to hypertension. Three individuals [II-
4, III-14, III-18] displayed clinical hypertension, one indi-
vidual [III-19] was asymptomatic (see Figure 1). Cell lines
were also isolated by the same method from 3 genetically
unrelated control individuals (A1, A2, A3). Cells were
grown in RPMI 1640 medium (Gibco) supplemented
with 15% fetal bovine serum (FBS).
Expression of VDAC, Bax and sKCa
Cells lines carrying the mtDNA tRNAIle 4263 A→G and
control cell lines were washed with ice-cold PBS and total
RNA was isolated using the TRIzol reagent (Invitrogen)
according to the manufacturer's instructions. RNA (2 μg)
was treated with ribonuclease-free deoxyribonuclease and
cDNA was synthesized using Moloney murine leukemia
virus reverse transcriptase (Invitrogen Life Technologies,
Carlsbad, CA); cDNA (2 μl) was subjected to 44 cycles of
PCR amplification, generating a single specific amplifica-
tion product of the expected size. PCR conditions were as
follows: denaturation for 30 sec at 94°C, annealing for 1
The Han Chinese pedigree with a maternal pattern of inheritance of hypertension Figure 1
The Han Chinese pedigree with a maternal pattern of inheritance of hypertension. Affected individuals are indi-
cated by filled symbols. The arrowhead denotes the proband. * denotes cardiac hypertrophy.
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min at 55°C (VDAC, Bax) or 58°C (sKCa), and 45 sec
extension at 72°C. PCR primers used in this study were:
VDAC sense, 5'-CTG AGT ACG GCC TGA CGT TT-3'; anti-
sense 5'-ACT CTG TCC CGT CAT TCA CA-3'; Bax sense 5'-
GCA GCT TAA CGC ACC AAT TA-3', antisense 5'-CAG
TTG AAG TTG CCG TCA GA-3'; sKCa sense 5'-GCA GCT
TAA CGC ACC AAT TA-3', antisense 5'-TGA GGG AAA
GGA CCA CTG AT-3'. Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) was used as the PCR internal control
using primers 5'-CTG CAC CAC CAA CTG CTT AG-3'
(sense) and 5'-TTC AGC TCA GGG ATG ACC TT-3' (anti-
sense). PCR reactions were in the linear range and were
performed in triplicate; products were visualized by elec-
trophoresis on 1.5% agarose gels and stained with ethid-
ium bromide. Band intensities were normalized to
GAPDH amplified in parallel and means were calculated
from the triplicate reactions.
For the study of Cyclosporin A (CsA, an inhibitor of
VDAC) on expression levels of VDAC, Bax and sKCa, cell
lines were incubated in the presence of CsA (Novartis, 2
μM) for 16 h before further analysis.
Confocal microscopy
Dual immunostaining was used to asssess the co-localiza-
tion of Bax and VDAC-1 polypeptides. Cells were grown
on glass coverslips in 6-well plates. After fixation (4%
paraformaldehyde in PBS), specimens were blocked with
5% BSA for 15 min, and incubated overnight with 200 μl
of primary antibody (anti-VDAC polyclonal antibody;
Cell Signaling Technology, Danvers, MA; or anti-Bax pol-
yclonal Antibody, NeoMarkers, Fremont, CA) diluted
1:100, followed by FITC green or rhodamine 123 labelled
secondary antibody for 60 min at 37°C, respectively. After
washing, slides were mounted with cover slips and
imaged using a confocal laser scanning system (RADI-
ANCE 2100, Bio-Rad, Hercules, CA). Excitation-emission
used an Argon 488 nm laser in conjunction with a 505-
525 nm filter for the Alexa Fluor 488, and a HeNe 543
laser with a 610 nm filter for the Alexa Fluor 546 [18].
Mitochondrial membrane potential and apoptosis 
measurements
The mitochondrial membrane potential (ΔΨm) was mon-
itored using the fluorescent reporter probe JC-1. Lym-
phoblastoid cell lines were incubated with 0.1 μM JC-1
(Alexis; Portland, OR) for 10 min at 37°C [19]. After this
loading period the cells were rinsed with phosphate-buff-
ered saline (PBS)/bovine serum albumin and resus-
pended into 0.1 μM JC-1 in PBS/bovine serum albumin at
room temperature [20]. ΔΨm was measured by cytofluor-
imetry (FL3). To evaluate the effects of CsA on ΔΨm, cell
lines were pre-incubated with CsA (Novartis, 2 μM) for 30
min and washed 5× in PBS before measurements. For
determinations of levels of apoptosis, cells were stained
with Annexin V/FITC and PI stain and imaged using laser-
scanning confocal microscopy (LSCM).
Statistical analyses
All data were presented as   ± SD. Comparison of con-
tinuous variables was performed using the unpaired Stu-
dent's t test. Statistical significance was set at P < 0.05.
Statistical analysis used SPSS software (version 11.0; SPSS
Inc, Chicago, IL).
Results
Expression of VDAC, Bax and sKCa
To study the effects of the mitochondrial tRNAIle A4263G
mutation on mitochondrial function, lymphoblastoid
cell lines were isolated from familial carriers of the muta-
tion (Figure 1) and from controls. Quantitative RT-PCR
was used to measure the mRNA expression levels of
VDAC, Bax and sKCa. As shown in Figure 2, the A4263G
mutation was associated with a significant (P  < 0.05)
increase in the levels of expression of both VDAC and Bax.
There was no change in the expression level of a control
channel, sKCa.
We then investigated the effects of Cyclosporin A (CsA), a
selective inhibitor of VDAC, on VDAC and Bax mRNA lev-
els. After incubation with CsA for 16 h, VDAC mRNA lev-
els decreased significantly and even lower than the control
levels (P < 0.05) while there was no significant change in
the levels of either Bax or sKCa mRNA (Figure 2).
Co-localization of VDAC and Bax protein
VDAC was localized on the outer membrane of the mito-
chondrial, but Bax was expressed in the cytoplasm, trans-
ferred to outer membrane of mitochondrial and
combined to VDAC under pathological state. To address
the relative localizations of VDAC and Bax in cell lines car-
rying the mtDNA tRNAIle A4263G mutation, specific anti-
bodies against these proteins were used for dual
immunofluorescence on mutant cells and controls. Local-
ization was imaged under confocal microscopy. Repre-
sentative sections are shown in Figure 3.
Separate VDAC (green) and Bax (red) fluorescence was
detected in control cell lines, indicating that the respective
polypeptides were separately localized. In contrast, in cell
lines from 2 tRNAIle A4263G subjects (III-14 and III-19)
co-localization of VDAC and Bax was revealed by intense
yellow fluorescence.
We also investigated the effects of CsA on co-localization.
Cell lines were incubated with CsA for 30 min prior to
analysis. Confocal imaging revealed that CsA treatment
abolished co-localization of VDAC and Bax.
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Mitochondrial membrane potential (ΔΨm) and apoptosis
The magnitude of ΔΨm is controlled by the activity of the
mitochondrial KATP (mitoKATP) and mitoKCa channels, as
well as by the mitochondrial permeability transition pore
(PTP) [21]. Cytometry images of lymphocytes loaded
with JC-1, a specific reporter of ΔΨm, revealed that mem-
brane potential in tRNAIle A4263G cells was decreased by
32% compared to controls (P < 0.05). After incubation
with CsA for 30 min the ΔΨm of both control and the
mutated cell lines was increased; the increase was 33.6%
in control cells but was 84.4% in III-14 mutant cells and
137.7% in III-19 mutant cells (Figure 4).
We then compared ΔΨm values between cell lines from
controls and subjects carrying the A4263G mutation, both
prior to and following incubation with CsA. As shown in
Figure 5, ΔΨm values were significantly decreased (P  <
0.05) in both cell lines harboring the mutation. CsA pre-
treatment increased ΔΨm in all cell lines, and after CsA
treatment there was no significant difference between
ΔΨm values in control and mutant cells (Figure 5).
Expression of VDAC, Bax and sKCa mRNAs Figure 2
Expression of VDAC, Bax and sKCa mRNAs. Con, cell line from the control group; Ht1, cell line from III-14; Ht2, cell line 
from II-4; Ht3, cell line from III-18; Ht4, cell line from III-19; CsA, cell line from III-14 after incubation with CsA (2 μM) for 16 h. 
A, expression of VDAC mRNA; B, expression of Bax mRNA; C, expression of sKCa channel mRNA.
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Localization of mitochondrial VDAC and Bax by confocal microscopy Figure 3
Localization of mitochondrial VDAC and Bax by confocal microscopy. Control, cell line from control group; 
Con+CsA, cell line incubated with CsA (2 μM) for 30 min; H-1, cell line from III-14; H-1+CsA, cell line incubated with CsA (2 
μM) for 30 min; H-4, cell line from III-19; H-4+CsA, cell line incubated with CsA (2 μM) for 30 min. VDAC was stained with 
FITC-green (green fluorescence); Bax was stained with rhodamine 123 (red fluorescence).
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To determine whether changes in VDAC mRNA levels,
localization, and ΔΨm values in lines from subjects carry-
ing the A4263G mutation are associated with changes in
apoptosis, cells were analyzed using Annexin V-FITC and
flow cytometry, a sensitive assay for apoptosis. Levels of
apoptosis were increased by 30% in cell lines carrying the
mutation (Figure 6, left panel). However, the difference
from controls was largely abolished by treatment with
CsA; this reduced levels of apoptosis by 24.6% in control
cells but by 56.9% in III-14 cells and by 67.1% in III-19
cells (Figure 6, right panel).
Discussion
Hypertension is a major risk factor for cardiovascular dis-
ease. Approximately 1 billion individuals worldwide and
130 million in China suffer from hypertension, and the
rates of morbidity and mortality associated with essential
hypertension (EHT) continue to rise [22]. Epidemiologi-
cal studies have indicated that the genetic variance under-
lying the predisposition to EHT ranges from 30-60% [1].
Mitochondrial DNA (mtDNA) mutations characterized
by maternal inheritance may make a significant contribu-
tion [23-26]. The Framingham heart study [27] on blood
pressure in 6421 participants from 1593 families esti-
mated that the heritability due to maternal effects was 5%
for multivariable-adjusted long-term average systolic
blood pressure, while the heritability of diastolic blood
pressure due to maternal effects was 4%.
We previously reported on a large Chinese Han family
with a predisposition to hypertension that demonstrated
a typical maternal pattern of inheritance. mtDNA
sequence analysis revealed a A4263G mutation in the
mtDNA tRNAIle  gene that is extraordinarily conserved
from bacteria to human. The voltage-dependent anion
channel (VDAC) is a highly conserved protein located on
the outer mitochondrial membrane [11]. VDAC, in asso-
ciation with ANT (adenine nucleotide translocator),
mediates the transport of ATP and ADP both into and out
of the mitochondrion [11]. VDAC closure inhibits the
release of ATP from the mitochondrion and promotes the
opening of KATP channels in the plasma membrane. VDAC
also mediates mitochondrial Ca2+ and may play a key role
in intracellular Ca2+ signaling [28]. tBid, a pro-apoptotic
member of the Bcl2 family, closes VDAC, and this may
partly account for the inhibition of VDAC reported during
apoptosis [29]. In contrast, anti-apoptotic Bcl-XL prevents
VDAC closure, a finding consistent with the interpretation
that VDAC opening is anti-apoptotic [30]. VDAC also
appears to be an anchor point for pro- and anti-apoptotic
proteins; it has been hypothesized that VDAC contributes
to increase of mitochondrial permeability that is involved
in the initiation of apoptosis.
We studied the effects of the mtDNA tRNAIle A4263G
mutation on VDAC function and apoptosis. We report
that expression level of VDAC mRNA in cell lines carrying
the mutation was significantly decreased. Although the
exact mechanism is unknown, it may be associated with
dysfunction of energy metabolism and consequent
increase in the levels of reactive oxygen species (ROS)
[31]. We hypothesis that high apoptosis of the mutated
cell lines was associated with increased expression of
VDAC mRNA, which could be inhibited by the CsA, a
kind of inhibitor of VDAC. In addition, imaging revealed
that VDAC was co-localized with Bax protein in cell lines
carrying the 4263 A→G mutation. These changes were
accompanied by a decrease in the mitochondrial mem-
brane potential ΔΨm and increased levels of apoptosis ver-
sus control cell lines. The role of VDAC in these processes
was confirmed by application of the selective VDAC
inhibitor Cyclosporin A (CsA): the inhibitor abolished co-
localization with Bax, restored ΔΨm to levels of control
CsA-treated cells, and decreased levels of apoptosis. Taken
together, these results suggest that the mtDNA A4263G
mutation, inferred to cause mis-charging of tRNAIle and
consequent amino acid substitutions in mitochondrial
proteins, may exert its pro-hypertensive effects by deregu-
lating the expression of VDAC, in turn leading to increases
in programmed cell death.
So we conclude that increased expression of mitochon-
drial VDAC and subcellular co-localization of VDAC/Bax
increases mitochondrial permeability and apoptosis in
cell lines carrying the mtDNA tRNAIle A4263G mutation.
Recent efforts to identify genes involved in essential
hypertension (EHT) have focused on genetic markers and
candidate genes in the nuclear genome. Nevertheless, the
pathophysiological mechanisms underlying EHT remain
unknown. Our results highlight the potential importance
of mitochondrial genes in the etiology of hypertension.
However, this work does not exclude a contribution from
the nuclear genome, and maternal inheritance of a predis-
position to EHT is likely to result from interactions
between mtDNA and nuclear mutations. So further
research will be required to elucidate the mechanisms
whereby nuclear-mitochondrial interactions can predis-
pose to the development of hypertension.
Finally this article we conclude that increased expression
of mitochondrial VDAC and subcellular co-localization of
VDAC/Bax increases mitochondrial permeability and
apoptosis.
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Mitochondrial potentials (ΔΨm) of cell lines from III-14, III-19 and from controls analyzed by flow cytometry Figure 4
Mitochondrial potentials (ΔΨm) of cell lines from III-14, III-19 and from controls analyzed by flow cytometry. 
The left and right figures show ΔΨm detected by flow cytometry before and after incubation with CsA (2 μM) for 30 min, 
respectively. A, cell lines of the control group; B, III-14; C, III-19.
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Comparison of ΔΨm of cell lines from patients and controls Figure 5
Comparison of ΔΨm of cell lines from patients and controls. The average ΔΨm value of cell lines from patients harbor-
ing the tRNAIle A4263G mutation was decreased by 32% compared to control cell lines. ΔΨm values of cell lines from both 
controls and patients were improved by CsA; control values increased by 33.6%, III-14 values increased by 84.4%, and III-19 
values increased by 137.7%.

Apoptosis of cell lines from III-14, III-19, and controls Figure 6
Apoptosis of cell lines from III-14, III-19, and controls. The left and right panels show flow cytometric analysis of apop-
tosis before and after incubation with CsA (2 μM) for 30 min, respectively.
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